Smith, M.D. The Normal Synovium. Open Rheumatol. J. 2011, 5, 100–106. [CrossRef]
Scanzello, C.R.; Goldring, S.R. The Role of Synovitis in Osteoarthritis Pathogenesis. Bone 2012, 51, 249–257. [CrossRef]
Croft, A.P.; Campos, J.; Jansen, K.; Turner, J.D.; Marshall, J.; Attar, M.; Savary, L.; Wehmeyer, C.; Naylor, A.J.; Kemble, S.; et al. Distinct Fibroblast Subsets Drive Inflammation and Damage in Arthritis. Nature 2019, 570, 246–251. [CrossRef]
Chou, C.-H.; Jain, V.; Gibson, J.; Attarian, D.E.; Haraden, C.A.; Yohn, C.B.; Laberge, R.-M.; Gregory, S.; Kraus, V.B. Synovial Cell Cross-Talk with Cartilage Plays a Major Role in the Pathogenesis of Osteoarthritis. Sci. Rep. 2020, 10, 10868. [CrossRef]
Zhang, F.; Wei, K.; Slowikowski, K.; Fonseka, C.Y.; Rao, D.A.; Kelly, S.; Goodman, S.M.; Tabechian, D.; Hughes, L.B.; Salomon-Escoto, K.; et al. Defining Inflammatory Cell States in Rheumatoid Arthritis Joint Synovial Tissues by Integrating Single-Cell Transcriptomics and Mass Cytometry. Nat. Immunol. 2019, 20, 928–942. [CrossRef]
Udalova, I.A.; Mantovani, A.; Feldmann, M. Macrophage Heterogeneity in the Context of Rheumatoid Arthritis. Nat. Rev. Rheumatol. 2016, 12, 472–485. [CrossRef]
Filer, A. The Fibroblast as a Therapeutic Target in Rheumatoid Arthritis. Curr. Opin. Pharmacol. 2013, 13, 413–419. [CrossRef]
Roemer, F.W.; Kassim Javaid, M.; Guermazi, A.; Thomas, M.; Kiran, A.; Keen, R.; King, L.; Arden, N.K. Anatomical Distribution of Synovitis in Knee Osteoarthritis and Its Association with Joint Effusion Assessed on Non-Enhanced and Contrast-Enhanced MRI. Osteoarthr. Cartil. 2010, 18, 1269–1274. [CrossRef]
Sellam, J.; Berenbaum, F. The Role of Synovitis in Pathophysiology and Clinical Symptoms of Osteoarthritis. Nat. Rev. Rheumatol. 2010, 6, 625–635. [CrossRef]
Griffin, T.M.; Scanzello, C.R. Innate Inflammation and Synovial Macrophages in Osteoarthritis Pathophysiology. Clin. Exp. Rheumatol. 2019, 37 (Suppl. 1), 57–63.
de Seny, D.; Bianchi, E.; Baiwir, D.; Cobraiville, G.; Collin, C.; Deliège, M.; Kaiser, M.-J.; Mazzucchelli, G.; Hauzeur, J.-P.; Delvenne, P.; et al. Proteins Involved in the Endoplasmic Reticulum Stress Are Modulated in Synovitis of Osteoarthritis, Chronic Pyrophosphate Arthropathy and Rheumatoid Arthritis, and Correlate with the Histological Inflammatory Score. Sci. Rep. 2020, 10, 14159. [CrossRef]
Hayashi, J.; Kihara, M.; Kato, H.; Nishimura, T. A Proteomic Profile of Synoviocyte Lesions Microdissected from Formalin-Fixed Paraffin-Embedded Synovial Tissues of Rheumatoid Arthritis. Clin. Proteom. 2015, 12, 20. [CrossRef]
Sehnert, B.; Cavcic, A.; Böhm, B.; Kalden, J.R.; Nandakumar, K.S.; Holmdahl, R.; Burkhardt, H. Antileukoproteinase: Modulation of Neutrophil Function and Therapeutic Effects on Anti-Type II Collagen Antibody-Induced Arthritis. Arthritis Rheum. 2004, 50, 2347–2359. [CrossRef]
Kamijo, S.; Nakajima, A.; Kamata, K.; Kurosawa, H.; Yagita, H.; Okumura, K. Involvement of TWEAK/Fn14 Interaction in the Synovial Inflammation of RA. Rheumatology 2008, 47, 442–450. [CrossRef]
Yang, Q.; Roehrl, M.H.; Wang, J.Y. Proteomic Profiling of Antibody-Inducing Immunogens in Tumor Tissue Identifies PSMA1, LAP3, ANXA3, and Maspin as Colon Cancer Markers. Oncotarget 2018, 9, 3996–4019. [CrossRef]
Tian, S.-Y.; Chen, S.-H.; Shao, B.-F.; Cai, H.-Y.; Zhou, Y.; Zhou, Y.-L.; Xu, A.-B. Expression of Leucine Aminopeptidase 3 (LAP3) Correlates with Prognosis and Malignant Development of Human Hepatocellular Carcinoma (HCC). Int. J. Clin. Exp. Pathol. 2014, 7, 3752–3762.
Wang, X.; Shi, L.; Deng, Y.; Qu, M.; Mao, S.; Xu, L.; Xu, W.; Fang, C. Inhibition of Leucine Aminopeptidase 3 Suppresses Invasion of Ovarian Cancer Cells through Down-Regulation of Fascin and MMP-2/9. Eur. J. Pharmacol. 2015, 768, 116–122. [CrossRef]
Zhang, S.; Yang, X.; Shi, H.; Li, M.; Xue, Q.; Ren, H.; Yao, L.; Chen, X.; Zhang, J.; Wang, H. Overexpression of Leucine Aminopeptidase 3 Contributes to Malignant Development of Human Esophageal Squamous Cell Carcinoma. J. Mol. Histol. 2014, 45, 283–292. [CrossRef]
Fang, C.; Zhang, J.; Yang, H.; Peng, L.; Wang, K.; Wang, Y.; Zhao, X.; Liu, H.; Dou, C.; Shi, L.; et al. Leucine Aminopeptidase 3 Promotes Migration and Invasion of Breast Cancer Cells through Upregulation of Fascin and Matrix Metalloproteinases-2/9 Expression. J. Cell. Biochem. 2019, 120, 3611–3620. [CrossRef]
He, X.; Huang, Q.; Qiu, X.; Liu, X.; Sun, G.; Guo, J.; Ding, Z.; Yang, L.; Ban, N.; Tao, T.; et al. LAP3 Promotes Glioma Progression by Regulating Proliferation, Migration and Invasion of Glioma Cells. Int. J. Biol. Macromol. 2015, 72, 1081–1089. [CrossRef]
Koide, N.; Kasamatsu, A.; Endo-Sakamoto, Y.; Ishida, S.; Shimizu, T.; Kimura, Y.; Miyamoto, I.; Yoshimura, S.; Shiiba, M.; Tanzawa, H.; et al. Evidence for Critical Role of Lymphocyte Cytosolic Protein 1 in Oral Cancer. Sci. Rep. 2017, 7, 43379. [CrossRef]
Chen, C.; Cai, Q.; He, W.; Lam, T.B.; Lin, J.; Zhao, Y.; Chen, X.; Gu, P.; Huang, H.; Xue, M.; et al. AP4 Modulated by the PI3K/AKT Pathway Promotes Prostate Cancer Proliferation and Metastasis of Prostate Cancer via Upregulating L-Plastin. Cell Death Dis. 2017, 8, e3060. [CrossRef]
Ge, X.; Liu, W.; Zhao, W.; Feng, S.; Duan, A.; Ji, C.; Shen, K.; Liu, W.; Zhou, J.; Jiang, D.; et al. Exosomal Transfer of LCP1 Promotes Osteosarcoma Cell Tumorigenesis and Metastasis by Activating the JAK2/STAT3 Signaling Pathway. Mol. Ther. Nucleic Acids 2020, 21, 900–915. [CrossRef]
Wabnitz, G.; Balta, E.; Samstag, Y. L-Plastin Regulates the Stability of the Immune Synapse of Naive and Effector T-Cells. Adv. Biol. Regul. 2017, 63, 107–114. [CrossRef]
Morley, S.C. The Actin-Bundling Protein L-Plastin Supports T-Cell Motility and Activation. Immunol. Rev. 2013, 256, 48–62. [CrossRef]
Chellaiah, M.A.; Ma, T.; Majumdar, S. L-Plastin Phosphorylation Regulates the Early Phase of Sealing Ring Formation by Actin Bundling Process in Mouse Osteoclasts. Exp. Cell Res. 2018, 372, 73–82. [CrossRef]
Chellaiah, M.A.; Majumdar, S.; Aljohani, H. Peptidomimetic Inhibitors of L-Plastin Reduce the Resorptive Activity of Osteoclast but Not the Bone Forming Activity of Osteoblasts In Vitro. PLoS ONE 2018, 13, e0204209. [CrossRef]
Kos, J.; Jevnikar, Z.; Obermajer, N. The Role of Cathepsin X in Cell Signaling. Cell Adh. Migr. 2009, 3, 164–166. [CrossRef]
Obermajer, N.; Svajger, U.; Bogyo, M.; Jeras, M.; Kos, J. Maturation of Dendritic Cells Depends on Proteolytic Cleavage by Cathepsin, X.J. Leukoc. Biol. 2008, 84, 1306–1315. [CrossRef]
Lechner, A.M.; Assfalg-Machleidt, I.; Zahler, S.; Stoeckelhuber, M.; Machleidt, W.; Jochum, M.; Nägler, D.K. RGD-Dependent Binding of Procathepsin X to Integrin Alphavbeta3 Mediates Cell-Adhesive Properties. J. Biol. Chem. 2006, 281, 39588–39597. [CrossRef]
Akkari, L.; Gocheva, V.; Kester, J.C.; Hunter, K.E.; Quick, M.L.; Sevenich, L.; Wang, H.-W.; Peters, C.; Tang, L.H.; Klimstra, D.S.; et al. Distinct Functions of Macrophage-Derived and Cancer Cell-Derived Cathepsin Z Combine to Promote Tumor Malignancy via Interactions with the Extracellular Matrix. Genes Dev. 2014, 28, 2134–2150. [CrossRef]
Jakoš, T.; Pišlar, A.; Jewett, A.; Kos, J. Cysteine Cathepsins in Tumor-Associated Immune Cells. Front. Immunol. 2019, 10, 2037. [CrossRef]
Vidak, E.; Javoršek, U.; Vizovišek, M.; Turk, B. Cysteine Cathepsins and Their Extracellular Roles: Shaping the Microenvironment. Cells 2019, 8, 264. [CrossRef]
Kelley, J.L.; Ozment, T.R.; Li, C.; Schweitzer, J.B.; Williams, D.L. Scavenger Receptor-A (CD204): A Two-Edged Sword in Health and Disease. Crit. Rev. Immunol. 2014, 34, 241–261. [CrossRef]
Guo, D.; Cao, C.; Zhang, X.; Xiang, L.; Shao, J. Scavenger Receptor SCARA5 Acts as an HMGB1 Recognition Molecule Negatively Involved in HMGB1-Mediated Inflammation in Fish Models. J. Immunol. 2016, 197, 3198–3213. [CrossRef]
Ojala, J.R.M.; Pikkarainen, T.; Elmberger, G.; Tryggvason, K. Progressive Reactive Lymphoid Connective Tissue Disease and Development of Autoantibodies in Scavenger Receptor A5-Deficient Mice. Am. J. Pathol. 2013, 182, 1681–1695. [CrossRef]
Zhang, H.; Liu, C.; Wang, X.; Wang, Y.; Zheng, J. SCARA5 Inhibits Gastric Cancer Progression via Epithelial-Mesenchymal Transition Suppression. J. Cancer 2021, 12, 2412–2421. [CrossRef]
Huang, J.; Zheng, D.-L.; Qin, F.-S.; Cheng, N.; Chen, H.; Wan, B.-B.; Wang, Y.-P.; Xiao, H.-S.; Han, Z.-G. Genetic and Epigenetic Silencing of SCARA5 May Contribute to Human Hepatocellular Carcinoma by Activating FAK Signaling. J. Clin. Investig. 2010, 120, 223–241. [CrossRef]
Wen, X.; Wang, N.; Zhang, F.; Dong, C. Overexpression of SCARA5 Inhibits Tumor Proliferation and Invasion in Osteosarcoma via Suppression of the FAK Signaling Pathway. Mol. Med. Rep. 2016, 13, 2885–2891. [CrossRef]
You, K.; Su, F.; Liu, L.; Lv, X.; Zhang, J.; Zhang, Y.; Liu, B. SCARA5 Plays a Critical Role in the Progression and Metastasis of Breast Cancer by Inactivating the ERK1/2, STAT3, and AKT Signaling Pathways. Mol. Cell. Biochem. 2017, 435, 47–58. [CrossRef]
Liu, J.; Hu, G.; Chen, D.; Gong, A.-Y.; Soori, G.S.; Dobleman, T.J.; Chen, X.-M. Suppression of SCARA5 by Snail1 Is Essential for EMT-Associated Cell Migration of A549 Cells. Oncogenesis 2013, 2, e73. [CrossRef]
Lee, H.; Lee, Y.J.; Choi, H.; Seok, J.W.; Yoon, B.K.; Kim, D.; Han, J.Y.; Lee, Y.; Kim, H.J.; Kim, J.-W. SCARA5 Plays a Critical Role in the Commitment of Mesenchymal Stem Cells to Adipogenesis. Sci. Rep. 2017, 7, 14833. [CrossRef]
Zhao, J.; Jian, L.; Zhang, L.; Ding, T.; Li, X.; Cheng, D.; Niu, S.; Sun, L.; Li, E.; Liu, S.; et al. Knockdown of SCARA5 Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Proliferation and Migration through Suppression of the PDGF Signaling Pathway. Mol. Med. Rep. 2016, 13, 4455–4460. [CrossRef]
Neves, J.; Zhu, J.; Sousa-Victor, P.; Konjikusic, M.; Riley, R.; Chew, S.; Qi, Y.; Jasper, H.; Lamba, D.A. Immune Modulation by MANF Promotes Tissue Repair and Regenerative Success in the Retina. Science 2016, 353, aaf3646. [CrossRef]
Chen, L.; Feng, L.; Wang, X.; Du, J.; Chen, Y.; Yang, W.; Zhou, C.; Cheng, L.; Shen, Y.; Fang, S.; et al. Mesencephalic Astrocyte-Derived Neurotrophic Factor Is Involved in Inflammation by Negatively Regulating the NF-KB Pathway. Sci. Rep. 2015, 5, 8133. [CrossRef]
Hou, C.; Mei, Q.; Song, X.; Bao, Q.; Li, X.; Wang, D.; Shen, Y. Mono-Macrophage-Derived MANF Protects Against Lipopolysaccharide-Induced Acute Kidney Injury via Inhibiting Inflammation and Renal M1 Macrophages. Inflammation 2021, 44, 693–703. [CrossRef] [PubMed]
Sousa-Victor, P.; Neves, J.; Cedron-Craft, W.; Ventura, P.B.; Liao, C.-Y.; Riley, R.R.; Soifer, I.; van Bruggen, N.; Kolumam, G.A.; Villeda, S.A.; et al. MANF Regulates Metabolic and Immune Homeostasis in Ageing and Protects against Liver Damage. Nat. Metab. 2019, 1, 276–290. [CrossRef] [PubMed]
Sousa-Victor, P.; Jasper, H.; Neves, J. Trophic Factors in Inflammation and Regeneration: The Role of ManF and CDNF. Front. Physiol. 2018, 9, 1629. [CrossRef] [PubMed]
Guo, F.; Snapp, E.L. ERdj3 Regulates BiP Occupancy in Living Cells. J. Cell Sci. 2013, 126 Pt 6, 1429–1439. [CrossRef]
Genereux, J.C.; Qu, S.; Zhou, M.; Ryno, L.M.; Wang, S.; Shoulders, M.D.; Kaufman, R.J.; Lasmézas, C.I.; Kelly, J.W.; Wiseman, R.L. Unfolded Protein Response-induced ER Dj3 Secretion Links ER Stress to Extracellular Proteostasis. EMBO J. 2015, 34, 4–19. [CrossRef]
Rheinländer, A.; Schraven, B.; Bommhardt, U. CD45 in Human Physiology and Clinical Medicine. Immunol. Lett. 2018, 196, 22–32. [CrossRef]
Cao, Z.; Gao, Q.; Fu, M.; Ni, N.; Pei, Y.; Ou, W.-B. Anaplastic Lymphoma Kinase Fusions: Roles in Cancer and Therapeutic Perspectives. Oncol. Lett. 2019, 17, 2020–2030. [CrossRef]
Soda, M.; Choi, Y.L.; Enomoto, M.; Takada, S.; Yamashita, Y.; Ishikawa, S.; Fujiwara, S.; Watanabe, H.; Kurashina, K.; Hatanaka, H.; et al. Identification of the Transforming EML4-ALK Fusion Gene in Non-Small-Cell Lung Cancer. Nature 2007, 448, 561–566. [CrossRef]
Ji, J.H.; Oh, Y.L.; Hong, M.; Yun, J.W.; Lee, H.-W.; Kim, D.; Ji, Y.; Kim, D.-H.; Park, W.-Y.; Shin, H.-T.; et al. Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer. PLoS Genet. 2015, 11, e1005467. [CrossRef]
Yin, Y.; Long, J.; Sun, Y.; Li, H.; Jiang, E.; Zeng, C.; Zhu, W. The Function and Clinical Significance of EIF3 in Cancer. Gene 2018, 673, 130–133. [CrossRef] [PubMed]
Lin, Y.-M.; Chen, Y.-R.; Lin, J.-R.; Wang, W.-J.; Inoko, A.; Inagaki, M.; Wu, Y.-C.; Chen, R.-H. EIF3k Regulates Apoptosis in Epithelial Cells by Releasing Caspase 3 from Keratin-Containing Inclusions. J. Cell Sci. 2008, 121 Pt 14, 2382–2393. [CrossRef] [PubMed]
Restelli, L.; Codrea, M.C.; Savoini, G.; Ceciliani, F.; Bendixen, E. LC-MS/MS Analysis of Visceral and Subcutaneous Adipose Tissue Proteomes in Young Goats with Focus on Innate Immunity and Inflammation Related Proteins. J. Proteom. 2014, 108, 295–305. [CrossRef]
Deng, R.-P.; He, X.; Guo, S.-J.; Liu, W.-F.; Tao, Y.; Tao, S.-C. Global Identification of O-GlcNAc Transferase (OGT) Interactors by a Human Proteome Microarray and the Construction of an OGT Interactome. Proteomics 2014, 14, 1020–1030. [CrossRef] [PubMed]
Furukawa, Y.; Lim, C.; Tosha, T.; Yoshida, K.; Hagai, T.; Akiyama, S.; Watanabe, S.; Nakagome, K.; Shiro, Y. Identification of a Novel Zinc-Binding Protein, C1orf123, as an Interactor with a Heavy Metal-Associated Domain. PLoS ONE 2018, 13, e0204355. [CrossRef] [PubMed]
Rahaman, S.N.A.; Mat Yusop, J.; Mohamed-Hussein, Z.-A.; Aizat, W.M.; Ho, K.L.; Teh, A.-H.; Waterman, J.; Tan, B.K.; Tan, H.L.; Li, A.Y.; et al. Crystal Structure and Functional Analysis of Human C1ORF123. PeerJ 2018, 6, e5377. [CrossRef]
Floudas, A.; Canavan, M.; McGarry, T.; Mullan, R.; Nagpal, S.; Veale, D.J.; Fearon, U. ACPA Status Correlates with Differential Immune Profile in Patients with Rheumatoid Arthritis. Cells 2021, 10, 647. [CrossRef]
Gupta, A.; Kaushik, R.; Kaushik, R.M.; Saini, M.; Kakkar, R. Association of Anti-Cyclic Citrullinated Peptide Antibodies with Clinical and Radiological Disease Severity in Rheumatoid Arthritis. Curr. Rheumatol. Rev. 2014, 10, 136–143. [CrossRef]
Kellgren, J.H.; Lawrence, J.S. Radiological Assessment of Osteo-Arthrosis. Ann. Rheum. Dis. 1957, 16, 494–502. [CrossRef]
Tak, P.P.; Thurkow, E.W.; Daha, M.R.; Kluin, P.M.; Smeets, T.J.M.; Meinders, A.E.; Breedveld, F.C. Expression of Adhesion Molecules in Early Rheumatoid Synovial Tissue. Clin. Immunol. Immunopathol. 1995, 77, 236–242. [CrossRef]
Costanza, B.; Turtoi, A.; Bellahcène, A.; Hirano, T.; Peulen, O.; Blomme, A.; Hennequière, V.; Mutijima, E.; Boniver, J.; Meuwis, M.-A.; et al. Innovative Methodology for the Identification of Soluble Biomarkers in Fresh Tissues. Oncotarget 2018, 9, 10665–10680. [CrossRef] [PubMed]
Bankhead, P.; Loughrey, M.B.; Fernández, J.A.; Dombrowski, Y.; McArt, D.G.; Dunne, P.D.; McQuaid, S.; Gray, R.T.; Murray, L.J.; Coleman, H.G.; et al. QuPath: Open Source Software for Digital Pathology Image Analysis. Sci. Rep. 2017, 7, 16878. [CrossRef] [PubMed]
Cox, J.; Hein, M.Y.; Luber, C.A.; Paron, I.; Nagaraj, N.; Mann, M. Accurate Proteome-Wide Label-Free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ. Mol. Cell. Proteom. 2014, 13, 2513–2526. [CrossRef] [PubMed]
